A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells

M. Akiyoshi, M. Kakei, M. Nakazaki, H. Tanaka

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Effects of a new hypoglycemic drug, N-[trans-4- isopropylcyclohexy- carbonyl]-D-phenylolanine (A-4166), on membrane current were investigated using the patch-clamp technique in single pancreatic β-cells isolated from rats. A-4166, at a concentration of 10 μM, depolarized membrane potential of β-cells and evoked action potentials in the presence of 2.8 mM glucose. The single ALP-sensitive K+ channel (K-ALP channel) current recorded in cell- attached membrane patches was reversibly inhibited by A-4166 (> 0.1 μM) without a change in the single-channel conductance of the K-ALP channel. Both A-4166 and tolbutamide inhibited the whole cell K-ALP channel current with half-maximum inhibition (IC50) of 0.23 and 12.8 μM, respectively (Hill coefficient = 1). In inside-out membrane patches, the IC50 with A-4166 occurred at 4.5 nM, in contrast to 0.7 μM for tolbutamide. A-4166 did not affect L- and T-type Ca2+ channels or the time-dependent outward current. We conclude that A-4166 specifically blocks the K-ALP channel and that the blockade is more potent than that of tolbutamide. The action of A-4166 underlies the mechanism by which the drug stimulates insulin secretion from β-cells.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume268
Issue number2 31-2
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

nateglinide
hypoglycemic agents
KATP Channels
Tolbutamide
tolbutamide
potassium channels
Hypoglycemic Agents
Rats
Membranes
rats
inhibitory concentration 50
Clamping devices
cells
Cell membranes
patch-clamp technique
new drugs
insulin secretion
action potentials
membrane potential
Insulin

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry
  • Agricultural and Biological Sciences(all)

Cite this

A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells. / Akiyoshi, M.; Kakei, M.; Nakazaki, M.; Tanaka, H.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 268, No. 2 31-2, 1995.

Research output: Contribution to journalArticle

@article{ed5090d838c343d5b8e7d8da986ca74c,
title = "A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells",
abstract = "Effects of a new hypoglycemic drug, N-[trans-4- isopropylcyclohexy- carbonyl]-D-phenylolanine (A-4166), on membrane current were investigated using the patch-clamp technique in single pancreatic β-cells isolated from rats. A-4166, at a concentration of 10 μM, depolarized membrane potential of β-cells and evoked action potentials in the presence of 2.8 mM glucose. The single ALP-sensitive K+ channel (K-ALP channel) current recorded in cell- attached membrane patches was reversibly inhibited by A-4166 (> 0.1 μM) without a change in the single-channel conductance of the K-ALP channel. Both A-4166 and tolbutamide inhibited the whole cell K-ALP channel current with half-maximum inhibition (IC50) of 0.23 and 12.8 μM, respectively (Hill coefficient = 1). In inside-out membrane patches, the IC50 with A-4166 occurred at 4.5 nM, in contrast to 0.7 μM for tolbutamide. A-4166 did not affect L- and T-type Ca2+ channels or the time-dependent outward current. We conclude that A-4166 specifically blocks the K-ALP channel and that the blockade is more potent than that of tolbutamide. The action of A-4166 underlies the mechanism by which the drug stimulates insulin secretion from β-cells.",
author = "M. Akiyoshi and M. Kakei and M. Nakazaki and H. Tanaka",
year = "1995",
language = "English",
volume = "268",
journal = "American Journal of Physiology",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "2 31-2",

}

TY - JOUR

T1 - A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells

AU - Akiyoshi, M.

AU - Kakei, M.

AU - Nakazaki, M.

AU - Tanaka, H.

PY - 1995

Y1 - 1995

N2 - Effects of a new hypoglycemic drug, N-[trans-4- isopropylcyclohexy- carbonyl]-D-phenylolanine (A-4166), on membrane current were investigated using the patch-clamp technique in single pancreatic β-cells isolated from rats. A-4166, at a concentration of 10 μM, depolarized membrane potential of β-cells and evoked action potentials in the presence of 2.8 mM glucose. The single ALP-sensitive K+ channel (K-ALP channel) current recorded in cell- attached membrane patches was reversibly inhibited by A-4166 (> 0.1 μM) without a change in the single-channel conductance of the K-ALP channel. Both A-4166 and tolbutamide inhibited the whole cell K-ALP channel current with half-maximum inhibition (IC50) of 0.23 and 12.8 μM, respectively (Hill coefficient = 1). In inside-out membrane patches, the IC50 with A-4166 occurred at 4.5 nM, in contrast to 0.7 μM for tolbutamide. A-4166 did not affect L- and T-type Ca2+ channels or the time-dependent outward current. We conclude that A-4166 specifically blocks the K-ALP channel and that the blockade is more potent than that of tolbutamide. The action of A-4166 underlies the mechanism by which the drug stimulates insulin secretion from β-cells.

AB - Effects of a new hypoglycemic drug, N-[trans-4- isopropylcyclohexy- carbonyl]-D-phenylolanine (A-4166), on membrane current were investigated using the patch-clamp technique in single pancreatic β-cells isolated from rats. A-4166, at a concentration of 10 μM, depolarized membrane potential of β-cells and evoked action potentials in the presence of 2.8 mM glucose. The single ALP-sensitive K+ channel (K-ALP channel) current recorded in cell- attached membrane patches was reversibly inhibited by A-4166 (> 0.1 μM) without a change in the single-channel conductance of the K-ALP channel. Both A-4166 and tolbutamide inhibited the whole cell K-ALP channel current with half-maximum inhibition (IC50) of 0.23 and 12.8 μM, respectively (Hill coefficient = 1). In inside-out membrane patches, the IC50 with A-4166 occurred at 4.5 nM, in contrast to 0.7 μM for tolbutamide. A-4166 did not affect L- and T-type Ca2+ channels or the time-dependent outward current. We conclude that A-4166 specifically blocks the K-ALP channel and that the blockade is more potent than that of tolbutamide. The action of A-4166 underlies the mechanism by which the drug stimulates insulin secretion from β-cells.

UR - http://www.scopus.com/inward/record.url?scp=0028927388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028927388&partnerID=8YFLogxK

M3 - Article

C2 - 7864093

AN - SCOPUS:0028927388

VL - 268

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1849

IS - 2 31-2

ER -